H.C. Wainwright Starts Biodesix (BDSX) at Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/18/2026
- Wall Street tumbles as worries about AI trade and high oil prices weigh
- Oil touches $110 a barrel for first time since May on Middle East, Russia supply fears
- Stay risk-off as higher real yields and AI volatility threaten stocks: BofA
- Apple’s first foldable iPhone sells out within minutes as preorders begin
- CoreWeave bond rout tests market's math on AI buildout
Tweet
Share
E-mailGet Alerts BDSX Hot Sheet
Price: $23.66 -4.25%
Rating Summary:
9 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 22 | New: 41
Rating Summary:
9 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 22 | New: 41
Join SI Premium – FREE
H.C. Wainwright analyst Yi Chen initiates coverage on Biodesix (NASDAQ: BDSX) with a Buy rating and a price target of $26.00.
For an analyst ratings summary and ratings history on Biodesix click here. For more ratings news on Biodesix click here.
Shares of Biodesix closed at $15.06 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Softbank Said To Weigh Buying Largest Us Security Firm Allied - Bloomberg
- Align Technology wins EU patent ruling against Angelalign's aligner feature
- GreenPower converts $2M in debentures to preferred shares for Nasdaq compliance
Create E-mail Alert Related Categories
New CoverageRelated Entities
Maynard Um, H.C. Wainwright, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
